Phase II study of Vigil ® DNA engineered immunotherapy asmaintenance in advanced stage ovarian cancer
Phase II study of Vigil® DNA engineered immunotherapy asmaintenance in advanced stage ovarian cancer Jonathan Oh , Minal Barve , Carolyn M. Matthews , E. Colin Koon , Thomas P. Heffernan , Bruce Fine , Elizabeth Grosen , Melanie K. Bergman , Evelyn L Fleming , Leslie R. DeMars , Loyd West , Daniel L. Spitz , Howard Goodman , Kenneth C. Hancock , Gladice Wallraven , Padmasini Kumar , Ernest Bognar , Luisa Manning , Beena O. Pappen , Ned Adams , Neil Senzer , John Nemunaitis a,b,c,d,⁎